Protein kinases as targets for anti-parasitic chemotherapy

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1697, Issue 1-2, 2004, Pages 155-168

  Doerig, Christian ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

CDK; Cyclin dependent kinase; Drug screening; Drug target; kDa; Kilodalton; MAPK; Parasite; Phosphorylation; PKA; PKG; Protein kinase A, or cyclic AMP dependent protein kinase; Protein kinase G, or Cyclic GMP dependent protein kinase; Protein kinase inhibitor

Indexed keywords

ANTIPARASITIC AGENT; PAULLONE DERIVATIVE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTOZOAL PROTEIN; PURVALANOL B; RECOMBINANT ENZYME;

ANTIPROTOZOAL ACTIVITY; CHEMICAL ANALYSIS; CONFERENCE PAPER; DRUG ACTIVITY; DRUG MECHANISM; DRUG TARGETING; EIMERIA; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME STRUCTURE; EXPRESSED SEQUENCE TAG; GENOMICS; HOST CELL; NONHUMAN; PHYLOGENY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; PROTOZOAL GENETICS; PROTOZOON; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TOXOPLASMA;

ANIMALS; ANTIPROTOZOAL AGENTS; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; PHYLOGENY; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTOZOA; PURINES;

ANIMALIA; EIMERIA; PLASMODIUM FALCIPARUM; PROTOZOA; TOXOPLASMA;

EID: 1542298986     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2003.11.021     Document Type: Conference Paper

References (93)

1. Sachs J., Malaney P. The economic and social burden of malaria. Nature. 415:2002;680-685.
2. Ridley R.G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature. 415:2002;686-693.
3. Williams R.B. A compartmentalised model for the estimation of the cost of coccidiosis to the world's chicken production industry. Int. J. Parasitol. 29:1999;1209-1229.
4. Greenwood B., Mutabingwa T. Malaria in 2002. Nature. 415:2002;670-672.
5. Bouteille B., Oukem O., Bisser S., Dumas M. Treatment perspectives for human African trypanosomiasis. Fundam. Clin. Pharmacol. 17:2003;171-181.
6. Burchmore R.J., Ogbunude P.O., Enanga B., Barrett M.P. Chemotherapy of human African trypanosomiasis. Curr. Pharm. Des. 8:2002;256-267.
7. Azziz R. The evaluation and management of hirsutism. Obstet. Gynecol. 101:2003;995-1007.
8. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 419:2002;498-511.
9. Holt R.A., Subramanian G.M., Halpern A., Sutton G.G., Charlab R., Nusskern D.R., Wincker P., Clark A.G., Ribeiro J.M., Wides R., Salzberg S.L., Loftus B., Yandell M., Majoros W.H., Rusch D.B., Lai Z., Kraft C.L., Abril J.F., Anthouard V., Arensburger P., Atkinson P.W., Baden H., de Berardinis V., Baldwin D., Benes V., Biedler J., Blass C., Bolanos R., Boscus D., Barnstead M., Cai S., Center A., Chatuverdi K., Christophides G.K., Chrystal M.A., Clamp M., Cravchik A., Curwen V., Dana A., Delcher A., Dew I., Evans C.A., Flanigan M., Grundschober-Freimoser A., Friedli L., Gu Z., Guan P., Guigo R., Hillenmeyer M.E., Hladun S.L., Hogan J.R., Hong Y.S., Hoover J., Jaillon O., Ke Z., Kodira C., Kokoza E., Koutsos A., Letunic I., Levitsky A., Liang Y., Lin J.J., Lobo N.F., Lopez J.R., Malek J.A., McIntosh T.C., Meister S., Miller J., Mobarry C., Mongin E., Murphy S.D., O'Brochta D.A., Pfannkoch C., Qi R., Regier M.A., Remington K., Shao H., Sharakhova M.V., Sitter C.D., Shetty J., Smith T.J., Strong R., Sun J., Thomasova D., Ton L.Q., Topalis P., Tu Z., Unger M.F., Walenz B., Wang A., Wang J., Wang M., Wang X., Woodford K.J., Wortman J.R., Wu M., Yao A., Zdobnov E.M., Zhang H., Zhao Q., Zhao S., Zhu S.C., Zhimulev I., Coluzzi M., della Torre A., Roth C.W., Louis C., Kalush F., Mural R.J., Myers E.W., Adams M.D., Smith H.O., Broder S., Gardner M.J., Fraser C.M., Birney E., Bork P., Brey P.T., Venter J.C., Weissenbach J., Kafatos F.C., Collins F.H., Hoffman S.L. The genome sequence of the malaria mosquito Anopheles gambiae. Science. 298:2002;129-149.
10. Katinka M.D., Duprat S., Cornillot E., Metenier G., Thomarat F., Prensier G., Barbe V., Peyretaillade E., Brottier P., Wincker P., Delbac F., El Alaoui H., Peyret P., Saurin W., Gouy M., Weissenbach J., Vivares C.P. Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi. Nature. 414:2001;450-453.
11. Baldauf S.L., Roger A.J., Wenk-Siefert I., Doolittle W.F. A kingdom-level phylogeny of eukaryotes based on combined protein data. Science. 290:2000;972-977.
12. Gull K. The biology of kinetoplastid parasites: insights and challenges from genomics and post-genomics. Int. J. Parasitol. 31:2001;443-452.
13. Waters A.P. The ribosomal RNA genes of Plasmodium. Adv. Parasitol. 34:1994;33-79.
14. Myler P.J., Audleman L., deVos T., Hixson G., Kiser P., Lemley C., Magness C., Rickel E., Sisk E., Sunkin S., Swartzell S., Westlake T., Bastien P., Fu G., Ivens A., Stuart K. Leishmania major Friedlin chromosome 1 has an unusual distribution of protein-coding genes. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2902-2906.
15. Doerig C., Chakrabarti D., Kappes B., Matthews K. The cell cycle in protozoan parasites. Prog. Cell Cycle Res. 4:2000;163-183.
16. Hu K., Mann T., Striepen B., Beckers C.J., Roos D.S., Murray J.M. Daughter cell assembly in the protozoan parasite Toxoplasma gondii. Mol. Biol. Cell. 13:2002;593-606.
17. Read M., Sherwin T., Holloway S.P., Gull K., Hyde J.E. Microtubular organization visualized by immunofluorescence microscopy during erythrocytic schizogony in Plasmodium falciparum and investigation of post-translational modifications of parasite tubulin. Parasitology. 106:1993;223-232.
18. Chitnis C.E., Blackman M.J. Host cell invasion by malaria parasites. Parasitol. Today. 16:2000;411-415.
19. Roos D.S. The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts. Parasitol. Today. 15:1999;41.
20. De Souza W. Basic cell biology of Trypanosoma cruzi. Curr. Pharm. Des. 8:2002;269-285.
21. Ward G.E., Fujioka H., Aikawa M., Miller L.H. Staurosporine inhibits invasion of erythrocytes by malarial merozoites. Exp. Parasitol. 79:1994;480-487.
22. Kappes B., Doerig C.D., Graser R. An overview of Plasmodium protein kinases. Parasitol. Today. 15:1999;449-454. (00001527 00001527).
23. Deng W., Baker D.A. A novel cyclic GMP-dependent protein kinase is expressed in the ring stage of the Plasmodium falciparum life cycle. Mol. Microbiol. 44:2002;1141-1151.
24. Gurnett A.M., Liberator P.A., Dulski P.M., Salowe S.P., Donald R.G., Anderson J.W., Wiltsie J., Diaz C.A., Harris G., Chang B., Darkin-Rattray S.J., Nare B., Crumley T., Blum P.S., Misura A.S., Tamas T., Sardana M.K., Yuan J., Biftu T., Schmatz D.M. Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic target. J. Biol. Chem. 277:2002;15913-15922.
25. Donald R.G., Allocco J., Singh S.B., Nare B., Salowe S.P., Wiltsie J., Liberator P.A. Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinase. Eukaryot. Cell. 1:2002;317-328.
26. Salowe S.P., Wiltsie J., Liberator P.A., Donald R.G. The role of a parasite-specific allosteric site in the distinctive activation behavior of Eimeria tenella cGMP-dependent protein kinase. Biochemistry. 41:2002;4385-4391.
27. Canaves J.M., Taylor S.S. Classification and phylogenetic analysis of the cAMP-dependent protein kinase regulatory subunit family. J. Mol. Evol. 54:2002;17-29.
28. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:1999;211-218.
29. Dorin D., Alano P., Boccaccio I., Ciceron L., Doerig C., Sulpice R., Parzy D. An atypical mitogen-activated protein kinase (MAPK) homologue expressed in gametocytes of the human malaria parasite Plasmodium falciparum. Identification of a MAPK signature. J. Biol. Chem. 274:1999;29912-29920.
30. Nakashima S., Wang S., Hisamoto N., Sakai H., Andoh M., Matsumoto K., Nozawa Y. Molecular cloning and expression of a stress-responsive mitogen-activated protein kinase-related kinase from Tetrahymena cells. J. Biol. Chem. 274:1999;9976-9983.
31. Muller I.B., Domenicali-Pfister D., Roditi I., Vassella E. Stage-specific requirement of a mitogen-activated protein kinase by Trypanosoma brucei. Mol. Biol. Cell. 13:2002;3787-3799.
32. Sharma A. Protein tyrosine kinase activity in human malaria parasite Plasmodium falciparum. Indian J. Exp. Biol. 38:2000;1222-1226.
33. Parsons M., Valentine M., Deans J., Schieven G.L., Ledbetter J.A. Distinct patterns of tyrosine phosphorylation during the life cycle of Trypanosoma brucei. Mol. Biochem. Parasitol. 45:1991;241-248.
34. Parsons M., Valentine M., Carter V. Protein kinases in divergent eukaryotes: identification of protein kinase activities regulated during trypanosome development. Proc. Natl. Acad. Sci. U. S. A. 90:1993;2656-2660.
35. Hunter T., Plowman G.D. The protein kinases of budding yeast: six score and more. Trends Biochem. Sci. 22:1997;18-22.
36. Li S., Wilson M.E., Donelson J.E. Leishmania chagasi: a gene encoding a protein kinase with a catalytic domain structurally related to MAP kinase kinase. Exp. Parasitol. 82:1996;87-96.
37. M. Wiese, D. Kuhn, C.G. Grünfelder. A protein kinase involved in flagellar length control. Eukaryotic Cell (in press).
38. Bracchi-Ricard V., Barik S., Delvecchio C., Doerig C., Chakrabarti R., Chakrabarti D. PfPK6, a novel cyclin-dependent kinase/mitogen-activated protein kinase-related protein kinase from Plasmodium falciparum. Biochem. J. 347(Pt. 1):2000;255-263.
39. Hammarton T., Mottram J.C., Doerig C. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation. Prog. Cell Cycle Res. 5:2003;91-101.
40. Doerig C.M., Parzy D., Langsley G., Horrocks P., Carter R., Doerig C.D. A MAP kinase homologue from the human malaria parasite Plasmodium falciparum. Gene. 177:1996;1-6.
41. Dorin D., Le Roch K., Sallicandro P., Alano P., Parzy D., Poullet P., Meijer L., Doerig C. Pfnek-1, a NIMA-related kinase from the human malaria parasite plasmodium falciparum biochemical properties and possible involvement in MAPK regulation. Eur. J. Biochem. 268:2001;2600-2608.
42. Mottram J.C., Smith G. A family of trypanosome cdc2-related protein kinases. Gene. 162:1995;147-152.
43. Doerig C., Endicott J., Chakrabarti D. Cyclin-dependent kinase homologues of Plasmodium falciparum. Int. J. Parasitol. 32:2002;1575-1585.
44. Le Roch K., Sestier C., Dorin D., Waters N., Kappes B., Chakrabarti D., Meijer L., Doerig C. Activation of a Plasmodium falciparum cdc2-related kinase by heterologous p25 and cyclin H. Functional characterization of a P. falciparum cyclin homologue. J. Biol. Chem. 275:2000;8952-8958.
45. Harper J.W., Adams P.D. Cyclin-dependent kinases. Chem. Rev. 101:2001;2511-2526.
46. Zaharevitz D.W., Gussio R., Leost M., Senderowicz A.M., Lahusen T., Kunick C., Meijer L., Sausville E.A. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res. 5:1999;2566-2569.
47. Schultz C., Link A., Leost M., Zaharevitz D.W., Gussio R., Sausville E.A., Meijer L., Kunick C. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. J. Med. Chem. 42:1999;2909-2919.
48. Leost M., Schultz C., Link A., Wu Y.Z., Biernat J., Mandelkow E.M., Bibb J.A., Snyder G.L., Greengard P., Zaharevitz D.W., Gussio R., Senderowicz A.M., Sausville E.A., Kunick C., Meijer L. Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. Eur. J. Biochem. 267:2000;5983-5994.
49. Knockaert M., Wieking K., Schmitt S., Leost M., Grant K.M., Mottram J.C., Kunick C., Meijer L. Intracellular targets of paullones. Identification following affinity purification on immobilized inhibitor. J. Biol. Chem. 277:2002;25493-25501.
50. Musrati R.A., Kollarova M., Mernik N., Mikulasova D. Malate dehydrogenase: distribution, function and properties. Gen. Physiol. Biophys. 17:1998;193-210.
51. Gleason W.B., Fu Z., Birktoft J., Banaszak L. Refined crystal structure of mitochondrial malate dehydrogenase from porcine heart and the consensus structure for dicarboxylic acid oxidoreductases. Biochemistry. 33:1994;2078-2088.
52. Birktoft J.J., Rhodes G., Banaszak L.J. Refined crystal structure of cytoplasmic malate dehydrogenase at 2.5-A resolution. Biochemistry. 28:1989;6065-6081.
53. Birktoft J.J., Fu Z., Carnahan G.E., Rhodes G., Roderick S.L., Banaszak L.J. Comparison of the molecular structures of cytoplasmic and mitochondrial malate dehydrogenase. Biochem. Soc. Trans. 17:1989;301-304.
54. Mottram J.C., Coombs G.H. Purification of particulate malate dehydrogenase and phosphoenolpyruvate carboxykinase from Leishmania mexicana mexicana. Biochim. Biophys. Acta. 827:1985;310-319.
55. Lang-Unnasch N. Purification and properties of Plasmodium falciparum malate dehydrogenase. Mol. Biochem. Parasitol. 50:1992;17-25.
56. Harmse L., van Zyl R., Gray N., Schultz P., Leclerc S., Meijer L., Doerig C., Havlik I. Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum. Biochem. Pharmacol. 62:2001;341-348.
57. Gray N.S., Wodicka L., Thunnissen A.M., Norman T.C., Kwon S., Espinoza F.H., Morgan D.O., Barnes G., LeClerc S., Meijer L., Kim S.H., Lockhart D.J., Schultz P.G. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 281:1998;533-538.
58. Knockaert M., Gray N., Damiens E., Chang Y.T., Grellier P., Grant K., Fergusson D., Mottram J., Soete M., Dubremetz J.F., Le Roch K., Doerig C., Schultz P., Meijer L. Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem. Biol. 7:2000;411-422.
59. Barik S., Taylor R.E., Chakrabarti D. Identification, cloning, and mutational analysis of the casein kinase 1 cDNA of the malaria parasite, Plasmodium falciparum. Stage-specific expression of the gene. J. Biol. Chem. 272:1997;26132-26138.
60. Parker M.D., Hyde R.J., Yao S.Y., McRobert L., Cass C.E., Young J.D., McConkey G.A., Baldwin S.A. Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy. Biochem. J. 349:2000;67-75.
61. Rager N., Mamoun C.B., Carter N.S., Goldberg D.E., Ullman B. Localization of the Plasmodium falciparum PfNT1 nucleoside transporter to the parasite plasma membrane. J. Biol. Chem. 276:2001;41095-41099.
62. Chishti A.H., Maalouf G.J., Marfatia S., Palek J., Wang W., Fisher D., Liu S.C. Phosphorylation of protein 4.1 in Plasmodium falciparum-infected human red blood cells. Blood. 83:1994;3339-3345.
63. Hermoso T., Fishelson Z., Becker S.I., Hirschberg K., Jaffe C.L. Leishmanial protein kinases phosphorylate components of the complement system. EMBO J. 10:1991;4061-4067.
64. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
65. Xiao Z., Waters N.C., Woodard C.L., Li Z., Li P.K. Design and synthesis of Pfmrk inhibitors as potential antimalarial agents. Bioorg. Med. Chem. Lett. 11:2001;2875-2878.
66. Grant K.M., Hassan P., Anderson J.S., Mottram J.C. The crk3 gene of Leishmania mexicana encodes a stage-regulated cdc2-related histone H1 kinase that associates with p12. J. Biol. Chem. 273:1998;10153-10159.
67. Doerig C., Meijer L., Mottram J.C. Protein kinases as drug targets in parasitic protozoa. Trends Parasitol. 18:2002;366-371.
68. Hassan P., Fergusson D., Grant K.M., Mottram J.C. The CRK3 protein kinase is essential for cell cycle progression of Leishmania mexicana. Mol. Biochem. Parasitol. 113:2001;189-198.
69. Mottram J.C., McCready B.P., Brown K.G., Grant K.M. Gene disruptions indicate an essential function for the LmmCRK1 cdc2-related kinase of Leishmania mexicana. Mol. Microbiol. 22:1996;573-583.
70. Wiese M. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host. EMBO J. 17:1998;2619-2628.
71. Hammarton T.C., Clark J., Douglas F., Boshart M., Mottram J.C. Stage-specific differences in cell cycle control in Trypanosoma brucei revealed by RNAi of a mitotic cyclin. J. Biol. Chem. 7:2003;7.
72. Menard R., Janse C. Gene targeting in malaria parasites. Methods. 13:1997;148-157.
73. Bishop A.C., Buzko O., Shokat K.M. Magic bullets for protein kinases. Trends Cell Biol. 11:2001;167-172.
74. Davies T.G., Bentley J., Arris C.E., Boyle F.T., Curtin N.J., Endicott J.A., Gibson A.E., Golding B.T., Griffin R.J., Hardcastle I.R., Jewsbury P., Johnson L.N., Mesguiche V., Newell D.R., Noble M.E., Tucker J.A., Wang L., Whitfield H.J. Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor. Nat. Struct. Biol. 9:2002;745-749.
75. Stowers A., Carter R. Current developments in malaria transmission-blocking vaccines. Expert Opin. Biol. Ther. 1:2001;619-628.
76. Vinetz J.M., Valenzuela J.G., Specht C.A., Aravind L., Langer R.C., Ribeiro J.M., Kaslow D.C. Chitinases of the avian malaria parasite Plasmodium gallinaceum, a class of enzymes necessary for parasite invasion of the mosquito midgut. J. Biol. Chem. 275:2000;10331-10341.
77. Kawamoto F., Alejo-Blanco R., Fleck S.L., Kawamoto Y., Sinden R.E. Possible roles of Ca2+ and cGMP as mediators of the exflagellation of Plasmodium berghei and Plasmodium falciparum. Mol. Biochem. Parasitol. 42:1990;101-108.
78. Silva-Neto M.A., Atella G.C., Shahabuddin M. Inhibition of Ca2+/calmodulin-dependent protein kinase blocks morphological differentiation of plasmodium gallinaceum zygotes to ookinetes. J. Biol. Chem. 277:2002;14085-14091.
79. Dobbelaere D.A., Fernandez P.C., Heussler V.T. Theileria parva: taking control of host cell proliferation and survival mechanisms. Cell. Microbiol. 2:2000;91-99.
80. Heussler V.T., Rottenberg S., Schwab R., Kuenzi P., Fernandez P.C., McKellar S., Shiels B., Chen Z.J., Orth K., Wallach D., Dobbelaere D.A. Hijacking of host cell IKK signalosomes by the transforming parasite Theileria. Science. 298:2002;1033-1036.
81. Baumgartner M., Chaussepied M., Moreau M.F., Werling D., Davis W.C., Garcia A., Langsley G. Constitutive PI3-K activity is essential for proliferation, but not survival, of Theileria parva-transformed B cells. Cell. Microbiol. 2:2000;329-339.
82. Feng G.J., Goodridge H.S., Harnett M.M., Wei X.Q., Nikolaev A.V., Higson A.P., Liew F.Y. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163:1999;6403-6412.
83. Hall B.S., Pereira M.A. Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect. Immun. 68:2000;2077-2081.
84. Cohen P. Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1:2002;309-315.
85. Waters N.C., Woodard C.L., Prigge S.T. Cyclin H activation and drug susceptibility of the Pfmrk cyclin dependent protein kinase from Plasmodium falciparum. Mol. Biochem. Parasitol. 107:2000;45-55.
86. Zhao Y., Pokutta S., Maurer P., Lindt M., Franklin R.M., Kappes B. Calcium-binding properties of a calcium-dependent protein kinase from Plasmodium falciparum and the significance of individual calcium-binding sites for kinase activation. Biochemistry. 33:1994;3714-3721.
87. Zhao Y., Franklin R.M., Kappes B. Plasmodium falciparum calcium-dependent protein kinase phosphorylates proteins of the host erythrocytic membrane. Mol. Biochem. Parasitol. 66:1994;329-343.
88. Garcia-Salcedo J.A., Nolan D.P., Gijon P., Gomez-Rodriguez J., Pays E. A protein kinase specifically associated with proliferative forms of Trypanosoma brucei is functionally related to a yeast kinase involved in the co-ordination of cell shape and division. Mol. Microbiol. 45:2002;307-319.
89. Spadafora C., Repetto Y., Torres C., Pino L., Robello C., Morello A., Gamarro F., Castanys S. Two casein kinase 1 isoforms are differentially expressed in Trypanosoma cruzi. Mol. Biochem. Parasitol. 124:2002;23-36.
90. Ellis J.G.t., Davila M.R., Chakrabarti R. Potential involvement of extracellular signal-regulated kinase 1 and 2 in encystation of a primitive eukaryote, Giardia lamblia. Stage-specific activation and intracellular localization. J. Biol. Chem. 278:2003;1936-1945.
91. Abel E.S., Davids B.J., Robles L.D., Loflin C.E., Gillin F.D., Chakrabarti R. Possible roles of protein kinase A in cell motility and excystation of the early diverging eukaryote Giardia lamblia. J. Biol. Chem. 276:2001;10320-10329.
92. Holton S., Merckx A., Burgess D., Doerig C., Noble M., Endicott J. Structures of P. falciparum PfPK5: testing the CDK regulation paradigm and mechanisms of small molecules inhibition. Structure. 11:2003;1329-1337.
93. Merckx A., Le Roch K., Nivez M.P., Dorin D., Alano P., Gutierrez G., Nebreda A.R., Goldring D., Whittle C., Patterson S., Chakrabarti D., Doerig C. Identification and initial characterization of three novel cyclin-related proteins of the human malaria parasite Plasmodium falciparum. J. Biol. Chem. 278:2003;39839-39850.